(Date:11/6/2009)...NA, Austria, November 6 EUCODIS Bi...acturing, and marketing enzymes for the,chemical i... research,agreement with Bio Sidus, the leading bi... The agreement gives EUCODIS Bioscience exclusiv... to Bio Sidus, proprietary collection of,psychroph...
(Date:11/6/2009)...ALLEY, Calif., Nov. 6 Calbiotech, ...all Business Innovative Research (SBIR) Phase I co...ial command. Under terms of the agreement, Calbiot...for the diagnosis of Dengue virus. ,, Dengue...ts a major threat to military forces deployed to t...
(Date:11/6/2009)... Calif., Nov. 6 Intarcia Therapeut... ITCA 650 (DUROS® continuous delivery of exen...s at the Ninth Annual Diabetes Technology Meeting ...scom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,,...ia ITCA 650 Lowers Plasma Glucose, HbA1c and Reduc...
(Date:11/5/2009)...ATION -- Gone hybrid . . . , Fuel economy rati...w posted at the www.fueleconomy.gov web site, wh...intains for the U.S. Department of Energy and the ...top 10 vehicles on the best fuel economy list are ...city; 48 highway). "This list proves that hybrids ...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3... 31 For the first time, scientists have shown tha...g an embryo) may be a potential new source of stem... prepublished online on February 12, 2009, in Blo...of Hematology. , , "Building on observations mad...whether stem cells could be detected in amniotic f...
...h 31 ArunA Biomedical, Inc., a leader in human em...y that it has co-developed a validated kit to prod...stems now part of Thermo Fisher. , , (Logo: ...U003LOGO ) , , In the spirit of collaboration A...e complete and fully validated induced pluripotent...
...ch 31 Intrinsic Bioprobes, Inc. today announced t...stitute to develop effective technologies for accu...ptides that improve diagnostic capabilities by eff...tes. The total cost of the two-and-a-half-year con...deral money provided by the NCI, and $146,088 is t...
Other Biology Technology:Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 2Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 3ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit 2Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins 2Mouse Anti-Human ULBP-3 Monoclonal Antibody, Unconjugated, Clone 166514 from R&D Systems
Rabbit Anti-Human CDC23 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-RFP Epitope Tag Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: